Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) FCF Margin (2018 - 2025)

TransMedics has reported FCF Margin over the past 8 years, most recently at 21.49% for Q4 2025.

  • Quarterly results put FCF Margin at 21.49% for Q4 2025, up 1651.0% from a year ago — trailing twelve months through Dec 2025 was 31.56% (up 4989.0% YoY), and the annual figure for FY2025 was 31.56%, up 4989.0%.
  • FCF Margin for Q4 2025 was 21.49% at TransMedics, down from 47.99% in the prior quarter.
  • Over the last five years, FCF Margin for TMDX hit a ceiling of 142.75% in Q4 2023 and a floor of 175.86% in Q3 2023.
  • Median FCF Margin over the past 5 years was 29.05% (2022), compared with a mean of 36.06%.
  • Biggest five-year swings in FCF Margin: skyrocketed 18856bps in 2021 and later plummeted -14084bps in 2023.
  • TransMedics' FCF Margin stood at 114.98% in 2021, then surged by 91bps to 10.11% in 2022, then soared by 1512bps to 142.75% in 2023, then plummeted by -97bps to 4.98% in 2024, then soared by 332bps to 21.49% in 2025.
  • The last three reported values for FCF Margin were 21.49% (Q4 2025), 47.99% (Q3 2025), and 58.15% (Q2 2025) per Business Quant data.